首页> 外国专利> MEDIUM FOR CULTURING HUMAN-DERIVED MONOCYTES AND A COMPOSITIOIN CONTAINING THE MONOCYTES AND ENDOTHELIAL PRECURSOR CELLS DIFFERENTIATED FROM THE MONOCYTES FOR TREATING ISCHEMIC DISEASES

MEDIUM FOR CULTURING HUMAN-DERIVED MONOCYTES AND A COMPOSITIOIN CONTAINING THE MONOCYTES AND ENDOTHELIAL PRECURSOR CELLS DIFFERENTIATED FROM THE MONOCYTES FOR TREATING ISCHEMIC DISEASES

机译:用于培养人源性单核细胞和包含单核细胞和内皮细胞前体细胞的复合物的培养基,这些成分不同于单核细胞,用于治疗缺血性疾病

摘要

PURPOSE: A medium for culturing monocytes is provided to improve survival ability and angiogenesis ability and to treat ischemia.;CONSTITUTION: A medium for culturing monocytes contains 20-400 ng/ml of each of EGF(epidermal growth factor), TPO(thrombopoietin), Flt-3L, IGF(insulin-like growth factor)-1, and bFGF(basic fibroblast growth factor) with a basal medium. The basal medium contains IMDM(Iscove`s Modified Dulbecco`s Medium) medium, DMEM, MEM, alpha-MEM, M-199, eagle`s basal medium, CMRL medium, RPMI 1640 medium, Ham`s F-10/12 medium, Fisher`s medium, McCoy`s 5A medium, Leibovitz`s medium, or MCDB. The medium additionally contains glutamine, FBS, penicillin, or streptomycin.;COPYRIGHT KIPO 2013
机译:目的:提供用于培养单核细胞的培养基,以提高生存能力和血管生成能力并治疗缺血。;构成:用于培养单核细胞的培养基包含20-400 ng / ml的EGF(表皮生长因子),TPO(血小板生成素) ,Flt-3L,IGF(胰岛素样生长因子)-1和bFGF(碱性成纤维细胞生长因子)与基础培养基。基础培养基包含IMDM(Iscove的改良Dulbecco培养基),DMEM,MEM,alpha-MEM,M-199,Eagle的基础培养基,CMRL培养基,RPMI 1640培养基,Ham的F-10 / 12中,费舍尔中,麦考伊5A中,莱博维茨中或MCDB。该介质还包含谷氨酰胺,FBS,青霉素或链霉素。; COPYRIGHT KIPO 2013

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号